COVID-19 Diagnostic Testing — Moving to the Point-of-Care: Part 2 in a Series

In our Part 1 of this blog series, we discussed the changes we are anticipating in the centralized testing model for COVID-19. There are some changes in store for the COVID-19 diagnostics market driven by the increase in the number of recent authorizations by the FDA for point-of-care (and point of need) testing.

[Read More]

Please to read the entire article.